References

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2024 · External reference

Global burden of primary liver cancer in 2020 and predictions to 2040

10.1016/j.jhep.2022.08.021 · 2022 · External reference

Hepatocellular carcinoma

10.1016/s0140-6736(22)01200-4 · 2022 · External reference

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

10.1038/nrgastro.2017.109 · 2018 · External reference

Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

10.1016/j.annonc.2025.02.006 · 2025 · External reference

Hepatocellular carcinoma in cirrhosis: Incidence and risk factors

10.1053/j.gastro.2004.09.014 · 2004 · External reference

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

10.1056/nejmoa2029349 · 2021 · External reference

MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis

2024 · External reference

Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis

10.3350/cmh.2023.0485 · 2024 · External reference

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

10.1002/hep.28368 · 2016 · External reference

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

10.1016/j.jhep.2024.08.028 · 2025 · External reference

Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma

10.1016/j.cgh.2024.03.028 · 2024 · External reference

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy

10.1016/j.jhep.2015.01.002 · 2015 · External reference

Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction

10.1136/gutjnl-2025-334928 · 2025 · External reference

Surgery and portal hypertension

1964 · External reference

Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade

10.1200/jco.2014.57.9151 · 2015 · External reference

Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis

10.7150/jca.21313 · 2017 · External reference

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma

10.1200/jco.21.02373 · 2022 · External reference

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma

2021 · External reference

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

10.1016/j.jhep.2016.09.008 · 2017 · External reference

AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma

10.1097/hep.0000000000000466 · 2023 · External reference

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy

10.1016/j.jhep.2022.06.001 · 2022 · External reference

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1996 · External reference

The importance of liver functional reserve in the non-surgical treatment of hepatocellular carcinoma

10.1016/j.jhep.2021.11.013 · 2022 · External reference

Metabolic Dysfunction-Associated Steatotic Liver Disease

10.1056/nejmra2412865 · 2025 · External reference

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

10.1016/j.cgh.2018.05.057 · 2019 · External reference

Hepatocellular carcinoma in patients without cirrhosis

10.3748/wjg.v31.i23.107100 · 2025 · External reference

BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update

2025 · External reference

Transection of the oesophagus for bleeding oesophageal varices

10.1002/bjs.1800600817 · 1973 · External reference

Assessment of prognosis of cirrhosis

10.1055/s-2008-1040325 · 2008 · External reference

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

10.1016/j.jhep.2016.09.008 · 2017 · External reference

Cirrhosis and the aetiology of hepatocellular carcinoma

10.1016/s0168-8278(87)80021-1 · 1987 · External reference

A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI)

10.1016/j.jhep.2012.06.022 · 2012 · External reference

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

10.1038/bjc.2012.92 · 2012 · External reference